Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Distinct germ line polymorphisms underlie glioma morphologic heterogeneity.

Jenkins RB, Wrensch MR, Johnson D, Fridley BL, Decker PA, Xiao Y, Kollmeyer TM, Rynearson AL, Fink S, Rice T, McCoy LS, Halder C, Kosel ML, Giannini C, Tihan T, O'Neill BP, Lachance DH, Yang P, Wiemels J, Wiencke JK.

Cancer Genet. 2011 Jan;204(1):13-8. doi: 10.1016/j.cancergencyto.2010.10.002.

2.

Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies.

Di Stefano AL, Enciso-Mora V, Marie Y, Desestret V, Labussière M, Boisselier B, Mokhtari K, Idbaih A, Hoang-Xuan K, Delattre JY, Houlston RS, Sanson M.

Neuro Oncol. 2013 May;15(5):542-7. doi: 10.1093/neuonc/nos284. Epub 2012 Nov 16.

3.

Genome-wide association study identifies five susceptibility loci for glioma.

Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, Hoang-Xuan K, El Hallani S, Idbaih A, Zelenika D, Andersson U, Henriksson R, Bergenheim AT, Feychting M, Lönn S, Ahlbom A, Schramm J, Linnebank M, Hemminki K, Kumar R, Hepworth SJ, Price A, Armstrong G, Liu Y, Gu X, Yu R, Lau C, Schoemaker M, Muir K, Swerdlow A, Lathrop M, Bondy M, Houlston RS.

Nat Genet. 2009 Aug;41(8):899-904. doi: 10.1038/ng.407. Epub 2009 Jul 5.

4.

Genetic risk profiles identify different molecular etiologies for glioma.

Simon M, Hosking FJ, Marie Y, Gousias K, Boisselier B, Carpentier C, Schramm J, Mokhtari K, Hoang-Xuan K, Idbaih A, Delattre JY, Lathrop M, Robertson LB, Houlston RS, Sanson M.

Clin Cancer Res. 2010 Nov 1;16(21):5252-9. doi: 10.1158/1078-0432.CCR-10-1502. Epub 2010 Sep 16.

5.

Fine mapping analysis of a region of 20q13.33 identified five independent susceptibility loci for glioma in a Chinese Han population.

Song X, Zhou K, Zhao Y, Huai C, Zhao Y, Yu H, Chen Y, Chen G, Chen H, Fan W, Mao Y, Lu D.

Carcinogenesis. 2012 May;33(5):1065-71. doi: 10.1093/carcin/bgs117. Epub 2012 Mar 2.

PMID:
22387365
6.

Interaction between 5 genetic variants and allergy in glioma risk.

Schoemaker MJ, Robertson L, Wigertz A, Jones ME, Hosking FJ, Feychting M, Lönn S, McKinney PA, Hepworth SJ, Muir KR, Auvinen A, Salminen T, Kiuru A, Johansen C, Houlston RS, Swerdlow AJ.

Am J Epidemiol. 2010 Jun 1;171(11):1165-73. doi: 10.1093/aje/kwq075. Epub 2010 May 12.

PMID:
20462933
7.

Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study.

Melin B, Dahlin AM, Andersson U, Wang Z, Henriksson R, Hallmans G, Bondy ML, Johansen C, Feychting M, Ahlbom A, Kitahara CM, Wang SS, Ruder AM, Carreón T, Butler MA, Inskip PD, Purdue M, Hsing AW, Mechanic L, Gillanders E, Yeager M, Linet M, Chanock SJ, Hartge P, Rajaraman P.

Int J Cancer. 2013 May 15;132(10):2464-8. doi: 10.1002/ijc.27922. Epub 2012 Nov 21.

8.

CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility.

Adel Fahmideh M, Lavebratt C, Schüz J, Röösli M, Tynes T, Grotzer MA, Johansen C, Kuehni CE, Lannering B, Prochazka M, Schmidt LS, Feychting M.

Carcinogenesis. 2015 Aug;36(8):876-82. doi: 10.1093/carcin/bgv074. Epub 2015 May 25.

PMID:
26014354
9.

Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.

Walsh KM, Rice T, Decker PA, Kosel ML, Kollmeyer T, Hansen HM, Zheng S, McCoy LS, Bracci PM, Anderson E, Hsuang G, Wiemels JL, Pico AR, Smirnov I, Molinaro AM, Tihan T, Berger MS, Chang SM, Prados MD, Lachance DH, Sicotte H, Eckel-Passow JE, Wiencke JK, Jenkins RB, Wrensch MR.

Neuro Oncol. 2013 Aug;15(8):1041-7. doi: 10.1093/neuonc/not051. Epub 2013 Jun 3.

10.

Genome-wide association study of glioma and meta-analysis.

Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS, Bondy M, Houlston R, Jenkins RB, Wrensch M, Yeager M, Ahlbom A, Albanes D, Andersson U, Freeman LE, Buring JE, Butler MA, Braganza M, Carreon T, Feychting M, Fleming SJ, Gapstur SM, Gaziano JM, Giles GG, Hallmans G, Henriksson R, Hoffman-Bolton J, Inskip PD, Johansen C, Kitahara CM, Lathrop M, Liu C, Le Marchand L, Linet MS, Lonn S, Peters U, Purdue MP, Rothman N, Ruder AM, Sanson M, Sesso HD, Severi G, Shu XO, Simon M, Stampfer M, Stevens VL, Visvanathan K, White E, Wolk A, Zeleniuch-Jacquotte A, Zheng W, Decker P, Enciso-Mora V, Fridley B, Gao YT, Kosel M, Lachance DH, Lau C, Rice T, Swerdlow A, Wiemels JL, Wiencke JK, Shete S, Xiang YB, Xiao Y, Hoover RN, Fraumeni JF Jr, Chatterjee N, Hartge P, Chanock SJ.

Hum Genet. 2012 Dec;131(12):1877-88. doi: 10.1007/s00439-012-1212-0. Epub 2012 Aug 11.

11.

Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking.

Lachance DH, Yang P, Johnson DR, Decker PA, Kollmeyer TM, McCoy LS, Rice T, Xiao Y, Ali-Osman F, Wang F, Stoddard SM, Sprau DJ, Kosel ML, Wiencke JK, Wiemels JL, Patoka JS, Davis F, McCarthy B, Rynearson AL, Worra JB, Fridley BL, O'Neill BP, Buckner JC, Il'yasova D, Jenkins RB, Wrensch MR.

Am J Epidemiol. 2011 Sep 1;174(5):574-81. doi: 10.1093/aje/kwr124. Epub 2011 Jul 8.

12.

Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population.

Chen H, Chen Y, Zhao Y, Fan W, Zhou K, Liu Y, Zhou L, Mao Y, Wei Q, Xu J, Lu D.

Am J Epidemiol. 2011 Apr 15;173(8):915-22. doi: 10.1093/aje/kwq457. Epub 2011 Feb 24.

PMID:
21350045
14.

Genetic causes of glioma: new leads in the labyrinth.

Melin B.

Curr Opin Oncol. 2011 Nov;23(6):643-7. doi: 10.1097/CCO.0b013e32834a6f61. Review.

PMID:
21825990
15.

Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.

Ghasimi S, Wibom C, Dahlin AM, Brännström T, Golovleva I, Andersson U, Melin B.

J Neurooncol. 2016 May;127(3):483-92. doi: 10.1007/s11060-016-2066-4. Epub 2016 Feb 2.

16.

[Genetics and brain gliomas].

Alentorn A, Labussière M, Sanson M, Delattre JY, Hoang-Xuan K, Idbaih A.

Presse Med. 2013 May;42(5):806-13. doi: 10.1016/j.lpm.2012.05.013. Epub 2012 Jul 11. Review. French.

PMID:
22789312
17.

Cancer susceptibility variants and the risk of adult glioma in a US case-control study.

Egan KM, Thompson RC, Nabors LB, Olson JJ, Brat DJ, Larocca RV, Brem S, Moots PL, Madden MH, Browning JE, Ann Chen Y.

J Neurooncol. 2011 Sep;104(2):535-42. doi: 10.1007/s11060-010-0506-0. Epub 2011 Jan 4. Erratum in: J Neurooncol. 2011 Sep;104(2):543.

18.

Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression.

Reyes-Botero G, Dehais C, Idbaih A, Martin-Duverneuil N, Lahutte M, Carpentier C, Letouzé E, Chinot O, Loiseau H, Honnorat J, Ramirez C, Moyal E, Figarella-Branger D, Ducray F; POLA Network..

Neuro Oncol. 2014 May;16(5):662-70. doi: 10.1093/neuonc/not235. Epub 2013 Dec 18.

19.

Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses.

Vogazianou AP, Chan R, Bäcklund LM, Pearson DM, Liu L, Langford CF, Gregory SG, Collins VP, Ichimura K.

Neuro Oncol. 2010 Jul;12(7):664-78. doi: 10.1093/neuonc/nop075. Epub 2010 Feb 17.

20.

RTEL1 tagging SNPs and haplotypes were associated with glioma development.

Li G, Jin T, Liang H, Zhang Z, He S, Tu Y, Yang H, Geng T, Cui G, Chen C, Gao G.

Diagn Pathol. 2013 May 17;8:83. doi: 10.1186/1746-1596-8-83.

Supplemental Content

Support Center